Proud For Profits
  • Investing
  • Stock
  • Latest News
  • Economy
  • Investing
  • Stock
  • Latest News
  • Economy
No Result
View All Result
Proud For Profits
No Result
View All Result
Home Stock

Pfizer gains as CEO said to meet activist Starboard

by
October 9, 2024
in Stock
0
Pfizer gains as CEO said to meet activist Starboard

Investing.com — Pfizer Inc. (NYSE:PFE) shares rose more than 3% on Wednesday following reports that CEO Albert Bourla is scheduled to meet with executives from activist hedge fund Starboard Value next week. 

The news reported by the Financial Times comes after a recent report from Reuters that said Starboard had taken a stake of approximately $1 billion in the pharmaceutical giant and is pushing for changes aimed at revitalizing the company’s performance. 

According to the Financial Times, the meeting, which includes Pfizer’s lead independent director Shantanu Narayen, who also serves as CEO of Adobe Systems (NASDAQ:ADBE), will involve discussions with Starboard’s chief executive Jeff Smith and Patrick Sullivan, head of its healthcare investments.

The discussions are said to signal an effort to address concerns raised by Starboard regarding Pfizer’s recent struggles to regain momentum following its pandemic-related highs.

Since taking the helm in 2019, Bourla has faced challenges as Pfizer’s revenues have decreased, particularly due to declining sales from COVID-19 products. 

Despite spending approximately $70 billion on acquisitions since 2020, including the notable $43 billion buyout of Seagen, Pfizer has yet to find a product that can effectively compensate for lost revenue from its COVID vaccine and treatment pill.

It was also reported that Pfizer’s recent product launches have fallen short of expectations, including a weaker-than-anticipated rollout of its respiratory syncytial virus (RSV) vaccine and disappointing clinical data from an obesity pill under development. 

While the specifics of Starboard’s recommendations remain unclear, their involvement suggests a push for strategic changes at Pfizer.

In a recent note to clients, Truist updated its models for Pfizer ahead of its earnings release, adjusting revenues primarily based on script tracking data and seasonality with Pfizer’s vaccine portfolio. 

“We now model 3Q24E total revenue of $15.0B vs $16.2B prior and 3Q24 adj. EPS of $0.48 vs. $0.50 prior,” said the firm

 

This post appeared first on investing.com
Previous Post

Milton threatens to upend shaky Florida homeowners insurance market

Next Post

Tesla robotaxi set to have two seats, Musk to discuss FSD for Semi, Bloomberg News reports

Next Post
Tesla robotaxi set to have two seats, Musk to discuss FSD for Semi, Bloomberg News reports

Tesla robotaxi set to have two seats, Musk to discuss FSD for Semi, Bloomberg News reports

Enter Your Information Below To Receive Trading Ideas and Latest News

    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    Popular News

    Trump wants to visit China again after he takes office: report

    Trump wants to visit China again after he takes office: report

    January 19, 2025
    Trump inauguration: Who is expected to attend, and who is boycotting?

    Trump inauguration: Who is expected to attend, and who is boycotting?

    January 19, 2025
    The Best Five Sectors, #3

    The Best Five Sectors, #3

    January 19, 2025
    Track all markets on TradingView

    About Proud For Profits

    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Main Categories

    • Investing
    • Stock
    • Latest News
    • Economy

    Latest News

    • Trump wants to visit China again after he takes office: report
    • Trump inauguration: Who is expected to attend, and who is boycotting?
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 proudforprofits.com | All Rights Reserved

    No Result
    View All Result
    • Investing
    • Stock
    • Latest News
    • Economy

    Copyright © 2025 proudforprofits.com | All Rights Reserved